September 14, 2014 | The Israeli company ReWalk Robotics had its IPO on Friday, raising a total of $36 million on NASDAQ. The company developed exoskeletons that enable paraplegics to walk, a tool recently approved by the Food & Drug Administration in the US. The company sold 3 million shares at $12 each with a company value of $136 million. The money raised came as a disappointment because the company expected to raise $58 million at a company value of $250-300 million, after money. However, against the company’s expectations, the IPO share price doubled, rising 113 percent to $25.60 on the first day of trading, reaching $26.90 in after market trading. ReWalk was founded in 2001 by Dr. Amit Goffer, the previous founder of Odin, which sold to Medtronic for $9 million.
Related posts

Israeli AI Safety Tool Among TIME’S Best Inventions For 2024

TAU Team Discovers Mechanism To Eliminate Cancerous Tumors

Ashdod Port Investing In Startups As Part Of Innovation Strategy

Facebook comments